Explore

Rapid Read Rapid Read
FDA Clears AI Tool EchoNext for Early Detection of Heart Failure via ECG

FDA Clears AI Tool EchoNext for Early Detection of Heart Failure via ECG

The U.S. Food and Drug Administration has cleared EchoNext, an AI tool developed by Pathway Labs in collaboration with NewYork-Presbyterian and Columbia University Irving Medical Center, to detect structural heart disease from routine ECGs. This tool can identify six cardiac conditions, including heart failure and valve disease, which are often asymptomatic in early stages. EchoNext was trained on a large dataset of ECGs and echocardiograms and validated across multiple hospitals. It aims to bridge the gap between routine ECGs and more costly echocardiograms, offering a new layer of screening that could lead to earlier diagnosis and treatment.
Trendline Trendline
G Showcases Diagnostic Development at ADLM 2026, Highlighting Innovation in Healthcare Technologies

G Showcases Diagnostic Development at ADLM 2026, Highlighting Innovation in Healthcare Technologies

G Showcases Diagnostic Development at ADLM 2026, Highlighting Innovation in Healthcare Technologies
Rapid Read Rapid Read
Telefónica Tech and Harrison.ai Collaborate on AI Tool for Enhanced X-Ray Diagnostics

Telefónica Tech and Harrison.ai Collaborate on AI Tool for Enhanced X-Ray Diagnostics

Telefónica Tech has partnered with Harrison.ai to introduce an AI-powered diagnostic tool designed to assist radiologists in analyzing chest X-rays. This tool, which will be implemented across regional health services in Spain, is capable of identifying up to 124 clinical findings from a single X-ray, including critical indicators for lung cancer. The AI system is intended to support medical staff by providing rapid second opinions, thereby aiding in the early detection and prioritization of urgent cases. The tool is integrated into existing clinical infrastructures, allowing for seamless access through standard web browsers, which can expedite initial triage decisions in emergency and primary care settings.
Trendline Trendline
Shiva Scientific Seeks Specialist to Advance Oncogenomics and Molecular Applications

Shiva Scientific Seeks Specialist to Advance Oncogenomics and Molecular Applications

Shiva Scientific Seeks Specialist to Advance Oncogenomics and Molecular Applications
USA Today USA Today
Biohacker Bryan Johnson claims he 'cloned' himself. Did he really?

Biohacker Bryan Johnson claims he 'cloned' himself. Did he really?

Bryan Johnson, who's become famous for his biohacking pursuits, says he has "cloned" himself. Experts disagree. Here's why.
Rapid Read Rapid Read
Researchers at DTU Use Quantum Computing to Enhance AI in Cancer Vaccine Design

Researchers at DTU Use Quantum Computing to Enhance AI in Cancer Vaccine Design

Researchers at the Technical University of Denmark (DTU) have utilized a photonic quantum computer to improve an AI model's ability to design peptides, which are crucial for the immune system to recognize diseased or infected cells. This study, which is still awaiting peer review, demonstrated that AI-designed peptides could successfully bind to human leukocyte antigen (HLA) molecules, a critical step in triggering an immune response. The AI used a generative adversarial network to design peptides, starting from a random point provided by a photonic quantum processor. This processor offers a unique kind of randomness that is difficult to replicate with classical computers, potentially allowing the AI to explore a broader range of peptide designs.
Rapid Read Rapid Read
Expansion of Rare Disease Genetic Testing Driven by Increased Diagnostic Demand

Expansion of Rare Disease Genetic Testing Driven by Increased Diagnostic Demand

The expansion of rare disease genetic testing is being driven by increasing diagnostic demand, as governments and healthcare organizations recognize the benefits of earlier diagnosis. This trend is particularly evident in Europe and Asia Pacific, where healthcare systems are emphasizing rare disease diagnosis to improve patient outcomes and healthcare efficiency. The adoption of genetic testing is expanding to support precision medicine approaches, with healthcare providers integrating advanced molecular diagnostics. The market for inherited metabolic disorder diagnostics is also growing due to expanded newborn screening programs and increased genetic testing. Additionally, reproductive genetic testing is expanding with advancements in technology and rising awareness of genetic disorders among prospective parents.
Rapid Read Rapid Read
OpenAI Introduces Health Feature in ChatGPT Amid Concerns Over Medical Advice Accuracy

OpenAI Introduces Health Feature in ChatGPT Amid Concerns Over Medical Advice Accuracy

OpenAI has launched a new feature in ChatGPT called Health, allowing users to upload medical records and connect health data from Apple Health. This development aims to assist users in tracking their health information over time. According to OpenAI, 300 million people already use ChatGPT weekly for health-related inquiries. The feature is designed to help users compare new test results with previous ones and explore how lifestyle factors like sleep and exercise impact their health. However, experts caution against relying solely on AI for medical advice. Tanzeem Choudhury, a health innovation expert at Cornell Tech, emphasizes the need for users to understand the risks of sharing personal data with AI. Concerns have been raised about the potential for AI to provide misleading or dangerous advice, as evidenced by recent incidents where ChatGPT's advice allegedly led to severe health consequences.
Rapid Read Rapid Read
Crnic Institute Study Reveals Biological Differences in Down Syndrome Co-occurring Conditions

Crnic Institute Study Reveals Biological Differences in Down Syndrome Co-occurring Conditions

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome have published a study in Nature Communications uncovering unique biological processes in individuals with Down syndrome who have various co-occurring conditions. This study, part of the Human Trisome Project, analyzed hundreds of blood samples to identify physiological differences among participants with Down syndrome, mapping changes in gene expression, protein levels, and immune cell types across 100 clinical traits. The findings provide an unprecedented atlas of the processes underlying medical complexity in Down syndrome, highlighting the effects of the extra chromosome 21 and other unique medical conditions.
Trendline Trendline
Oura's Expansion into Comprehensive Health Platform Highlights Broader Wellness Impact

Oura's Expansion into Comprehensive Health Platform Highlights Broader Wellness Impact

Oura's Expansion into Comprehensive Health Platform Highlights Broader Wellness Impact
Trendline Trendline
University of California San Diego Develops Smart Ring for Real-Time Biochemical Monitoring

University of California San Diego Develops Smart Ring for Real-Time Biochemical Monitoring

University of California San Diego Develops Smart Ring for Real-Time Biochemical Monitoring
Trendline Trendline
Aetna's Strategic Investments Aim to Enhance Provider Trust and Interoperability

Aetna's Strategic Investments Aim to Enhance Provider Trust and Interoperability

Aetna's Strategic Investments Aim to Enhance Provider Trust and Interoperability